This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Brett P. Giroir, M.D, Acting Commissioner of Food and Drugs

No Significant Event

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 11/21/2019
Location: Boston, MA
Subject: Massachusetts Biotechnology Council (MassBio) Meeting
FDA Participant/Group: STEPHANIE CACCOMO;
Non FDA Participant/Group: Bob Coughlin, Zach Stanley (MassBio); Katie Oppenheimer (Sanofi); Paul Kim, Tom Barker (Foley Hoag LLP); Josh Cohen, Justin Klee (Amylyx Pharmaceuticals); Alex Waldron, Yuri Maricich (Pear Therapeutics); Ramani Varanasi (X-Biotix Therapeutics); Michelle Avery (Summit Therapeutics); David Altarac (Entasis Therapeutics); Kristin Wolff (Bluebird Bio);

Event Date: 11/21/2019
Location: Boston, MA
Subject: 2019 STAT Summit; Fireside Chat - Where No FDA Has Gone Before
FDA Participant/Group: STEPHANIE CACCOMO;
Non FDA Participant/Group: Attendees from industry, academia, and the media

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 11/18/2019
Location: Washington, DC
Subject: National Hemophilia Foundation Gene Therapy Summit Panel: Who Needs What Data When, to Aid in Decision Making?
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from industry, academia, and the media

Event Date: 11/19/2019
Location: Rockville, MD
Subject: Cure Sickle Cell panel: Consistency in Measurements
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from industry, academia, and media

Event Date: 11/20/2019
Location: Boston, MA
Subject: Gene Therapy Analytical Development Summit: FDA Perspective on Analytical Regulatory Expectation
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from industry, academia, and the media

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 11/21/2019
Location: Silver Spring, MD
Subject: Pharmacogenomic Testing
FDA Participant/Group: TIFFANY FARCHIONE; ELLEN FLANNERY; TOBY LOWE; TIMOTHY STENZEL; JOHN CONCATO; BRITTANY SCHUCK; MICHAEL PACANOWSKI; PATRIZIA CAVAZZONI; PETER STEIN; ROBERT BERLIN; KATHERINE DONIGAN; COURTNEY LIAS; JENNIFER TOMASELLO; ELIZABETH HILLEBRENNER; JACQUELINE CORRIGAN CURAY; WENDY RUBINSTEIN;
Non FDA Participant/Group: Al Guida (Guide Consulting Services); Phyllis Foxworth (Depression & Bi-Polar Support Alliance); Andrew Sperling (National Alliance for Mental Illness); Joe Parks, Reyna Taylor (National Council for Behavioral Health); Madeline Reinert (Mental Health America);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event